Panoramic Investment Advisors »

Celldex Therapeutics shares owned by Panoramic Investment Advisors

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Panoramic Investment Advisors from 13F filings

Historical chart of Panoramic Investment Advisors investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Panoramic Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Panoramic Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $273k 6.5k 41.97
2023-12-31 $258k 6.5k 39.66
2022-12-31 $290k 6.5k 44.57

More positions owned by Panoramic Investment Advisors

Spdr Ser Tr Portfolio S&p500 (SPLG)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Fidelity Wise Origin Bitcoin SHS
Ishares Bitcoin Tr SHS
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Vanguard Whitehall Fds High Div Yld (VYM)
Abbott Laboratories (ABT)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Panoramic Investment Advisors

Top funds holding Celldex Therapeutics

Wellington Management Company
Eventide Asset Management
Vanguard Group
Kynam Capital Management
Point72 Asset Management
Bellevue Group
Marshall Wace
Redmile Group
Octagon Capital Advisors
Commodore Capital
Jennison Associates
5AM Venture Management
Goldman Sachs Group
Sphera Funds Management
T. Rowe Price Associates

View all funds holding Celldex Therapeutics